PRODIGE 52 -UCGI 29-CCTG/CO.27 (IROCAS) A multicenter, international, randomized phase III trial comparing adjuvant modified (m)FOLFIRINOX to mFOLFOX6 in patients with high-risk stage III (pT4 and/or N2) colon cancer (A UNICANCER GI-PRODIGE trial)

ANNÉE

2018

AUTEURS

Bennouna J, Andre T, Miglianico L, Campion L, Mineur L, Heng Lam Y, Hire St, Artru P, Bouche O, Borde F, Aleba A, Rajpar LS, Rebischung C, Touchefeu Y, Kavan P, Gill S, Asmis T, JouffroyZeller C, Emile JF, Taieb J

CONGRÈS/REVUE

ASCO

LIEN PUBLICATIONS ASSOCIÉES